Skip to content
healthcare.dev

TAZICEF

NDC 0409-5084, CEFTAZIDIME, injection, powder, for solution, from Hospira, Inc..

Product NDC
0409-5084
Status
Listed
Labeler
Hospira, Inc.
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA062662
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0409-5084 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CEFTAZIDIME2 g/1

Pharmacologic classes

Cephalosporin Antibacterial [EPC]; Cephalosporins [CS]

Package NDCNDC-11Package
0409-5084-110040950841110 VIAL, SINGLE-DOSE in 1 CARTON (0409-5084-11) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0409-5084-13)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/40d48c5d-650e-461b-a67b-7e65772d1b92
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0409-5084

Use it

Look up 0409-5084 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0409-5084 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0409-5084. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.